by Brendan Sweeney | Mar 15, 2018 | Compliance, Uncategorized
Our understanding of the FDA’s mandate for UDI is focused on driving value through the following: more accurate reporting and analysis of adverse events; reducing medical errors; enhanced analysis of devices in the market; managing recalls; and setting a foundation...
Recent Comments